Innovations safeguarding pharma cold chain

The pandemic has fast-tracked the need for innovation and the increased need for transformations in the healthcare sector, especially in the transportation, logistics and last mile delivery of the Covid-19 vaccine. As transportation of medicines and pharmaceuticals is increasing due to the delivery of the Covid-19 vaccine, container solution providers around the world who deliver and process temperature-controlled pharma products have been rising to the challenge posed by the pharma industry in several ways.
In line with this, va-Q-tec – a German tech firm that sells products for temperature controlling and insulation-vacuum, insulation panels and phase change materials has signed a deal with Turkish Cargo to deploy its thermal container va-Q-tainer on the airline’s fleet.
The container has a special low-temperature service free of dry ice down to -50°C, which is best suited for carrying and transporting the Covid-19 vaccines. va-Q-tainers can maintain various temperature ranges between -70 °C upto +25 °C for several days inside the container. In addition, the underlying production processes have been certified as climate-neutral, according to the UN Greenhouse Gas Protocol since 2020.